Log In

Home
    - Create Journal
    - Update
    - Download

Scribbld
    - News
    - Paid Accounts
    - Invite
    - To-Do list
    - Contributors

Customize
    - Customize
    - Create Style
    - Edit Style

Find Users
    - Random!
    - By Region
    - By Interest
    - Search

Edit ...
    - User Info
    - Settings
    - Your Friends
    - Old Entries
    - Userpics
    - Password

Need Help?
    - Password?
    - FAQs
    - Support Area


Someone wrote in [info]oihjalzfpo,
GbEfkDZxnurWcj
What's the last date I can post this to to arrive in time for Christmas? what happened to prolatis The drug, also known as pertuzumab, is designed for patients whose tumors contain excess levels of the HER-2 protein. It was developed by Roche's Genentech unit. In the neoadjuvant, or pre-surgical setting, the hope is that it will shrink tumors and make them easier to remove.

(Read comments)

Post a comment in response:

From:
( )Anonymous- this user has disabled anonymous and non-friend posting. You may post here if oihjalzfpo lists you as a friend.
Identity URL: 
Username:
Password:
Don't have an account? Create one now.
Subject:
No HTML allowed in subject
  
Message:

Type the letters and numbers you see below, to prove that you're not a spam robot. If you can't read the text, type "AUDIO" and take a sound test instead.


Answer:

 



scribbld is part of the horse.13 network
Design by Jimmy B.
Logo created by hitsuzen.
Scribbld System Status